LTRN 8-K 2026-10-01
Lantern Pharma Inc. (LTRN) 8-K dated 2026-10-01 — accession 0001493152-26-045344.
Lantern Pharma Inc. (LTRN) is a biotechnology company listed on US.
Lantern Pharma Inc. filed a 8-K on 2026-10-01. Accession 0001493152-26-045344.
This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for LTRN is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The LTRN SEC hub lists recent forms. The stock page is the research view.